IRCT2016022726788N1已完成2 期
combination of metformin and standard chemotherapy decreases recurrence rate of epithelial ovarian cancers
Vice chancellor of research, Shiraz University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 80 years（—）
- 性别
- Female
入选标准
- •all women with histopathologic diagnosis of epithelial ovarian carcinoma undergone total abdominal hysterectomy and bilateral salpingo-oophorectomy in shahid faghihi hospital(shiraz)march 2011 to march 2015 were included.
- •those with the following criteria were excluded from the study:
- •diabetic patients; patients with liver or gastrointestinal disorders or renal failure; patients unable to tolerate metformin; patients who received neoadjuvant chemotherapy before cytoreductive surgery; patients whose ovarian cancer is secondary to other cancers
排除标准
- 未提供
研究者
相似试验
尚未招募
1 期
Metabolism Prescription Combined with Metformin in the Intervention of Type 2 Diabetes Mellitus Combined with Obesity: a Multicenter Randomized Controlled Double-Blind Clinical StudyType 2 Diabetes Mellitus combined with ObesityITMCTR2000003636onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
已完成
2 期
A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast CancerMetastatic Breast CancerNCT01310231Ozmosis Research Inc.40
暂停
1 期
A Randomised Double-Blind Controlled Trial of Metformin and Atorvastatin – with treatment commenced following prostatic biopsy and ceasing just before radical prostatectomy - to guide subsequent patient managementCancer - ProstateProstate cancerACTRN12615000571572niversity of Queensland Centre for Clinical Research80
尚未招募
不适用
Treatment with metformin to reduce insulin requirements in Diabetes in PregnancyGestational diabetes mellitusSLCTR/2011/009one
招募中
2 期
Metformin with chemotherapy in Triple negative and Her2neu positive breastcancer - a randomisedstudyCTRI/2022/05/042576All India Institute of Medical Sciences